Peripheral regulatory CD8+CD28−KLRG1+ T cells as markers of disease and treatment response in rheumatoid arthritis

Charlotte Thompson, Richard Beatson, Ruth Davies, Claire Greenhill, Simon A. Jones, Anwen S. Williams, Gareth W. Jones, Ernest HS Choy
doi: https://doi.org/10.1101/2020.09.02.20186635

Article Information

doi 
https://doi.org/10.1101/2020.09.02.20186635
History 
  • September 3, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Charlotte Thompson1,*,#,
  2. Richard Beatson2,*,
  3. Ruth Davies1,
  4. Claire Greenhill1,
  5. Simon A. Jones1,
  6. Anwen S. Williams1,
  7. Gareth W. Jones3 and
  8. Ernest HS Choy1
  1. 1CREATE Centre, Section of Rheumatology, Institute of Infection and Immunity, Cardiff University School of Medicine, United Kingdom
  2. 2School of Cancer and Pharmaceutical Sciences, King’s College London, United Kingdom
  3. 3School of Cellular and Molecular Medicine, University of Bristol, United Kingdom
  1. ↵#Corresponding author
    Charlotte Thompson MD, Cardiff University School of Medicine, Tenovus Building, Heath Park, Cardiff CF14 4XN, Wales, United Kingdom, E-mail: C.Thompson2{at}bsms.ac.uk

  1. ↵* Both authors contributed equally to this work

Back to top
Posted September 03, 2020.
Download PDF
Data/Code
Email
Peripheral regulatory CD8+CD28−KLRG1+ T cells as markers of disease and treatment response in rheumatoid arthritis
Charlotte Thompson, Richard Beatson, Ruth Davies, Claire Greenhill, Simon A. Jones, Anwen S. Williams, Gareth W. Jones, Ernest HS Choy
medRxiv 2020.09.02.20186635; doi: https://doi.org/10.1101/2020.09.02.20186635
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area